The global metal implants and medical alloys market size was estimated to be USD 15.98 billion in 2023 and is expected to reach at USD 49.28 billion by 2034 with a CAGR of 10.78% during the forecast period 2024-2034. Increasing prevalence of chronic diseases such as orthopedic, dental, degenerative joint disorders, rising geriatric population, surge in technological advancement in metal implants, growing demand for minimally invasive surgeries, increasing initiatives by leading market players, rising regulatory approvals for the metallic implants by regulatory authorities, surge in launch of advanced metal & alloy medical implants, and growing partnerships & collaborations within market players are some of the key factors boosting the market growth.
Surge in launch of advanced metal & alloy medical implants is predicted to boost the market growth during the forecast period. Metal and alloy implants are employed to substitute damaged biological structures caused by issues such as cartilage problems, trauma, or bone disorders. Consequently, the growing demand for medical implants due to various health conditions is projected to lead to an expansion in the production of metal and alloy implants. For instance, in March 2022, Total Joint Orthopedics, Inc. (TJO) is excited to declare the official introduction of its Klassic Knee System featuring Aurum Technology during the American Academy of Orthopaedic Surgeons' (AAOS) 2022 Annual Meeting. Aurum marks the initial phase of TJO's long-term strategy to minimize the utilization of Cobalt Chrome in orthopedic implants.
By type, titanium was the highest revenue-grossing segment in the global metal implants and medical alloys market in 2023 owing to the benefits of titanium over other materials, such as its high strength, stiffness, stronger capacity to withstand strain, superior corrosion resistant qualities, non-magnetic, non-allergic, & attaches to the bone without the need for any extra coating and increasing regulatory approvals. For instance, in July 2023, Jiangsu Vilory has received approval from the National Drug Administration for the registration of their Class III medical device product called "Dental Laser Selective Melted Titanium Alloy Powder." This represents a significant advancement in the company's utilization of metal powder products within the medical sector. Additionally, stainless steel is predicted to grow at fastest CAGR during the forecast period owing to its initial adoption for surgical procedures and rising demand for temporary implant procedures.
By application, dental was the highest revenue-grossing segment in the global metal implants and medical alloys market in 2023 owing to the increasing prevalence of dental problems, growing aging population, rising launch of new products. For instance, in June 2022, ZimVie Inc. has unveiled the FDA-cleared T3 PRO Tapered Implant and Encode Emergence Healing Abutment for the United States market. The T3 PRO represents the latest addition to ZimVie's dental implant lineup, enhancing the established solutions offered by the T3 Tapered Implant. Additionally, orthopedic is predicted to grow at fastest CAGR during the forecast period owing to the surge in prevalence of geriatric population, growing number of sports injuries, increasing burden of orthopedic disorders.
By end-user, hospitals & clinics was the highest revenue-grossing segment in the global metal implants and medical alloys market in 2023 owing to the rising need for tertiary care across every sector, growing research & development activities by hospitals in order to increase the effectiveness of treatments & more effectively serve patient needs, & they concentrate their limited resources on well-designed referral networks, and increasing regulatory approvals. For instance, In March 2022, OSSIO Inc. has reached a noteworthy achievement in its commercial journey by obtaining its third regulatory clearance from the United States Food and Drug Administration (FDA) within the past four months. This development sets the stage for the availability of more implants utilizing OSSIOfiber Intelligent Bone Regeneration Technology to patients and surgeons in the coming six months. Additionally, ambulatory surgical centers (ASC) is predicted to grow at fastest CAGR during the forecast period. It serves as an efficient, cost-effective replacement for an operating room at a hospital, and outpatient surgical centers are usually simpler to access.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising geriatric population, surge in prevalence of chronic diseases, growing product launches by market players, increasing research & development activities, and rising approvals by regulatory bodies. For instance, in March 2023, Bioretec Ltd, a leader in bioresorbable technology and the sole healthcare company providing bioresorbable metallic implants in the United States, the largest orthopedic implant market, has disclosed that it has obtained market authorization from the Food and Drug Administration (FDA) for its innovative RemeOsTM trauma screw. This screw is intended for use in the healing process of fractures that were aligned with the clinical trial. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of dental disorders, increasing technological advancement in metal implants, rising demand for minimally invasive surgeries, and surge in launch of novel implant products. For instance, in June 2022, OsssDsign has introduced OssDsign Cranial PSI in the Japanese market. This product is a personalized cranial implant crafted from 3D-printed medical-grade titanium and coated with a regenerative calcium phosphate composition.
Surge in launch of advanced metal & alloy medical implants is predicted to boost the market growth during the forecast period. Metal and alloy implants are employed to substitute damaged biological structures caused by issues such as cartilage problems, trauma, or bone disorders. Consequently, the growing demand for medical implants due to various health conditions is projected to lead to an expansion in the production of metal and alloy implants. For instance, in March 2022, Total Joint Orthopedics, Inc. (TJO) is excited to declare the official introduction of its Klassic Knee System featuring Aurum Technology during the American Academy of Orthopaedic Surgeons' (AAOS) 2022 Annual Meeting. Aurum marks the initial phase of TJO's long-term strategy to minimize the utilization of Cobalt Chrome in orthopedic implants.
By type, titanium was the highest revenue-grossing segment in the global metal implants and medical alloys market in 2023 owing to the benefits of titanium over other materials, such as its high strength, stiffness, stronger capacity to withstand strain, superior corrosion resistant qualities, non-magnetic, non-allergic, & attaches to the bone without the need for any extra coating and increasing regulatory approvals. For instance, in July 2023, Jiangsu Vilory has received approval from the National Drug Administration for the registration of their Class III medical device product called "Dental Laser Selective Melted Titanium Alloy Powder." This represents a significant advancement in the company's utilization of metal powder products within the medical sector. Additionally, stainless steel is predicted to grow at fastest CAGR during the forecast period owing to its initial adoption for surgical procedures and rising demand for temporary implant procedures.
By application, dental was the highest revenue-grossing segment in the global metal implants and medical alloys market in 2023 owing to the increasing prevalence of dental problems, growing aging population, rising launch of new products. For instance, in June 2022, ZimVie Inc. has unveiled the FDA-cleared T3 PRO Tapered Implant and Encode Emergence Healing Abutment for the United States market. The T3 PRO represents the latest addition to ZimVie's dental implant lineup, enhancing the established solutions offered by the T3 Tapered Implant. Additionally, orthopedic is predicted to grow at fastest CAGR during the forecast period owing to the surge in prevalence of geriatric population, growing number of sports injuries, increasing burden of orthopedic disorders.
By end-user, hospitals & clinics was the highest revenue-grossing segment in the global metal implants and medical alloys market in 2023 owing to the rising need for tertiary care across every sector, growing research & development activities by hospitals in order to increase the effectiveness of treatments & more effectively serve patient needs, & they concentrate their limited resources on well-designed referral networks, and increasing regulatory approvals. For instance, In March 2022, OSSIO Inc. has reached a noteworthy achievement in its commercial journey by obtaining its third regulatory clearance from the United States Food and Drug Administration (FDA) within the past four months. This development sets the stage for the availability of more implants utilizing OSSIOfiber Intelligent Bone Regeneration Technology to patients and surgeons in the coming six months. Additionally, ambulatory surgical centers (ASC) is predicted to grow at fastest CAGR during the forecast period. It serves as an efficient, cost-effective replacement for an operating room at a hospital, and outpatient surgical centers are usually simpler to access.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising geriatric population, surge in prevalence of chronic diseases, growing product launches by market players, increasing research & development activities, and rising approvals by regulatory bodies. For instance, in March 2023, Bioretec Ltd, a leader in bioresorbable technology and the sole healthcare company providing bioresorbable metallic implants in the United States, the largest orthopedic implant market, has disclosed that it has obtained market authorization from the Food and Drug Administration (FDA) for its innovative RemeOsTM trauma screw. This screw is intended for use in the healing process of fractures that were aligned with the clinical trial. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of dental disorders, increasing technological advancement in metal implants, rising demand for minimally invasive surgeries, and surge in launch of novel implant products. For instance, in June 2022, OsssDsign has introduced OssDsign Cranial PSI in the Japanese market. This product is a personalized cranial implant crafted from 3D-printed medical-grade titanium and coated with a regenerative calcium phosphate composition.
Segmentation: Metal Implants And Medical Alloys Market Report 2022 - 2033
Metal Implants And Medical Alloys Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Stainless Steel
- Titanium
- Cobalt Chrome
- Others
Metal Implants And Medical Alloys Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Spinal Fusion
- Dental
- Stent
- Orthopedic
- Craniofacial
- Other
Metal Implants And Medical Alloys Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals & Clinics
- Ambulatory Surgical Centers (ASC)
- Others
Metal Implants And Medical Alloys Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Metal Implants And Medical Alloys Market: Type Estimates & Trend Analysis
8. Metal Implants And Medical Alloys Market: Application Estimates & Trend Analysis
9. Metal Implants And Medical Alloys Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Metal Implants And Medical Alloys Market
12. Europe Global Metal Implants And Medical Alloys Market
13. Asia Pacific Global Metal Implants And Medical Alloys Market
14. Latin America Global Metal Implants And Medical Alloys Market
15. MEA Global Metal Implants And Medical Alloys Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Abbott
- ATI Specialty Alloys & Components
- Royal DSM
- Bioplate Inc
- Total Joint Orthopedics Inc.
- Ametek Specialty Products
- ZimVie Inc.
- Johnson Matthey PLC
- Bioretec Ltd
- QuesTek Innovations LLC
- Carpenter Technology Corporation
- OSSIO Inc.
- Zimmer Biomet Holdings Inc.
- G & S Titanium (Fort Wayne Metals)
- Karl Leibinger Medizintechnik (KLS Martin Group)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 15.98 Billion |
| Forecasted Market Value ( USD | $ 49.28 Billion |
| Compound Annual Growth Rate | 10.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
![Orthopaedic Implants Market by Product (Knee, Hip, Elbow, Ankle, Shoulder, Foot, Wrist), Material [Metals (Stainless Steel, Titanium Alloy, Cobalt Chromium, Nitinol) Polymers, Ceramics, Hybrid], End User (Hospitals, ASCs, Trauma) - Global Forecast to 2029 - Product Image](http://www.researchandmarkets.com/product_images/12714/12714279_60px_jpg/orthopaedic_implants_market.jpg)
